Smart dosing could make MDR-TB treatment safer
Disease control
Recruiting now
This study tests whether adjusting the dose of the antibiotic linezolid based on regular blood tests can reduce harmful side effects in people being treated for multidrug-resistant tuberculosis (MDR-TB). The trial will enroll 150 patients in Guinea who are on a standard 6-month r…
Phase: PHASE4 • Sponsor: Marco Schiuma • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC